Based on previous reports supporting the contribution of GABAergic dysfunction in Rett syndrome progression and the alteration of the GABAA-A1 expression, we hypothesized that MeCP2 disturbance might directly affect the density of GABAA receptors, rather than such an altered expression being a secondary effect of an overall GABAergic dysfunction. The gene discussed is MECP2; the disease is atypical Rett syndrome.